ResearcherHarvard UniversityActive in the last 2 years
Zhou Luan
Matched on ORCID iD 0009-0008-0692-2862; OpenAlex author ID A5056322692. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers
Papers 6
- Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasion in Pancreatic Cancer. Co-author DOI 10.1002/advs.75426↗
- CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK. Co-author DOI 10.1038/s41389-026-00634-0↗
- Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug Conjugate. Co-author DOI 10.1158/1078-0432.ccr-25-2333↗
- Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer. Co-author DOI 10.14309/ctg.0000000000000487↗
- Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Last author DOI 10.1186/s12935-021-02390-0↗
- Targeting the prohibitin scaffold-CRAF kinase interaction in RAS-ERK-driven pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/1476-4598-13-38↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bin Cheng · 4 shared papers, 2021–2026 · strength 0.79
- Paper CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK. DOI 10.1038/s41389-026-00634-0↗
- Paper Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasi… DOI 10.1002/advs.75426↗
- Paper Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Panc… DOI 10.14309/ctg.0000000000000487↗
- Yuchong Zhao · 4 shared papers, 2021–2026 · strength 0.79
- Paper CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK. DOI 10.1038/s41389-026-00634-0↗
- Paper Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasi… DOI 10.1002/advs.75426↗
- Paper Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Panc… DOI 10.14309/ctg.0000000000000487↗
- Wang Peng · 2 shared papers, 2026 · strength 0.50
- Mengdie Cao · 2 shared papers, 2026 · strength 0.50
- Jingwen Liang · 2 shared papers, 2026 · strength 0.50
- Shiru Chen · 2 shared papers, 2026 · strength 0.50
- Luyao Liu · 2 shared papers, 2026 · strength 0.50
- Yun Wang · 2 shared papers, 2021–2022 · strength 0.28
- Paper Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Panc… DOI 10.14309/ctg.0000000000000487↗
- Paper Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. DOI 10.1186/s12935-021-02390-0↗
- Yuko Kitagawa · 1 shared paper, 2025 · strength 0.19
- Hiroki Ozawa · 1 shared paper, 2025 · strength 0.19
- Minoru Kitago · 1 shared paper, 2025 · strength 0.19
- Rosalie C. Sears · 1 shared paper, 2025 · strength 0.19
- Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.19
- Donald W. Kufe · 1 shared paper, 2025 · strength 0.19
- Joseph Douglas Mancias · 1 shared paper, 2025 · strength 0.19
- Ronghua Wang · 1 shared paper, 2022 · strength 0.15
- Jinlin Wang · 1 shared paper, 2022 · strength 0.15
- Fan He · 1 shared paper, 2014 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.